Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 06:11 am Purchase |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
ACUTA CAPITAL PARTNERS LLC | 863,100 5.600% |
863,100 (New Position) |
Filing History |
| 2021-02-12 4:57 pm Purchase |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
ORBIMED ADVISORS LLC | 732,323 4.770% |
732,323 (New Position) |
Filing History |
| 2021-02-10 7:02 pm Purchase |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
Renaissance Technologies LLC | 221,374 1.440% |
221,374 (New Position) |
Filing History |
| 2021-02-02 1:04 pm Purchase |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
Atlas Venture Fund VII L P | 292,182 1.900% |
292,182 (New Position) |
Filing History |
| 2020-07-01 4:01 pm Sale |
2020-06-26 | 13D | Larimar Therapeutics, Inc. LRMR |
Deerfield Mgmt, L.P. | 5,144,539 33.500% |
-946,711 (-15.54%) |
Filing History |
| 2020-06-30 4:46 pm Sale |
2020-06-26 | 13D | Larimar Therapeutics, Inc. LRMR |
CHONDRIAL THERAPEUTICS HOLDINGS LLC | 0 0.000% |
-6,091,250 (Position Closed) |
Filing History |